New research from the Garvan Institute of Medical Research and UNSW Sydney identifies more than 1,000 genetic switches that operate differently between male and female immune cells. These findings provide a biological explanation for why women are diagnosed with autoimmune diseases at significantly higher rates than men. Lupus, for instance, affects nine women for every one man. Understanding these genetic drivers is a critical step toward moving away from one-size-fits-all treatments.
The study analyzed 1.25 million immune cells from nearly 1,000 healthy participants to compare how immune systems function at a granular level. Previous research often relied on bulk blood analysis, which obscured the specific behaviors of individual cell types. By using single-cell technology, researchers observed that female immune cells show higher activity in inflammatory pathways, while male cells focus more on basic maintenance and protein production.
Surprisingly, most of these genetic switches are located on non-sex chromosomes. This challenges long-held assumptions that male and female immune differences are driven primarily by X and Y chromosomes. These switches function like volume controls, influencing how genes are activated. The research highlights specific variants linked to autoimmune conditions, suggesting that women start with a biological baseline that makes them more prone to their own immune system mistakenly attacking healthy tissue.
Medical science has historically focused heavily on male study groups, which limits the efficacy of treatments for women. Dr. Seyhan Yazar and the research team argue that the immune system must be studied with sex in mind to improve diagnostic accuracy and care. Moving toward precision medicine requires acknowledging these baseline differences in how male and female immune systems operate at a genetic level.
This work suggests that the future of autoimmune care involves targeting specific genetic pathways rather than using broad, systemic suppressors. Tailoring treatments to a patient's biological makeup is a path forward for better management of chronic conditions. The data provides a clear mandate for more inclusive research practices across the medical field.